Evolutionary Tree Capital Management, LLC Dexcom Inc Transaction History

Evolutionary Tree Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $2.2 Million - $2.8 Million	19,967 New	19,967 $2.26 Million
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $1.57 Million - $3.08 Million	23,161 Added 418.67%	28,693 $2.14 Million
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $30,387 - $42,054	-323 Reduced 5.52%	5,532 $2.83 Million
Q4 2021 Feb 11, 2022	SELL	$129.87 - $162.82 $53,896 - $67,570	-415 Reduced 6.62%	5,855 $3.14 Million
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $52,928 - $71,017	-496 Reduced 7.33%	6,270 $3.43 Million
Q2 2021 Aug 12, 2021	BUY	$80.99 - $107.93 $16,278 - $21,693	201 Added 3.06%	6,766 $2.89 Million
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $284,809 - $351,821	3,359 Added 104.77%	6,565 $2.36 Million
Q4 2020 Feb 10, 2021	BUY	$78.0 - $104.5 $250,068 - $335,027	3,206 New	3,206 $1.19 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Evolutionary Tree Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolutionary Tree Capital Management, LLC with notifications on news.